REGN
Regeneron Pharmaceuticals, Inc.
October 30, 2026 · pre-market
- Rarity
- 1.99
- Peak move
- +7.50%
- Float cap
- $83.2B
Still running — rarity and peak move can only rise from here.
Regeneron Pharmaceuticals, Inc. is a fully integrated biotechnology company that invents, develops, manufactures, and commercializes medicines for people with serious diseases. Its products and product candidates target eye diseases, allergic and inflammatory diseases, cancer, cardiovascular and metabolic diseases, neurological diseases, hematologic conditions, infectious diseases, and rare diseases. It provides these medicines to patients and medical professionals.
Where do you see this going?
no votes yetVote to see the split.
What we found
no events · 0 from SEC or newswire · 0 timed with the moveNothing found.We searched SEC filings, the newswires and the open web across the three days around this move and found no public information that explains it.